Serum Soluble ST2 as a Biochemical Marker of Acute Heart Failure. Future Areas of Research

Journal of the American College of Cardiology

Volumn 52, Issue 18, 2008, Pages 1466-1467

  Díez, Javier ^a  

^a Centre of Applied Medical Research   (Spain)

Author keywords

biochemical marker; heart failure; soluble ST2

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; INTERLEUKIN 1 RECEPTOR;

ACUTE HEART FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD LEVEL; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DYSPNEA; EDITORIAL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RAT; RISK ASSESSMENT;

ACUTE DISEASE; BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; INFLAMMATION; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 54049088654     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.045     Document Type: Editorial

References (13)

1. Weinberg E.O., Shimpo M., De Keulenaer G.W., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
2. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., and Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117 (2007) 1538-1549
3. Shimpo M., Morrow D.A., Weinberg E.O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
4. Sabatine M.S., Morrow D.A., Higgins L.J., et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117 (2008) 1936-1944
5. Januzzi Jr. J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50 (2007) 607-613
6. Mueller T., Dieplinger B., Gegenhuber A., Poelz W., Pacher R., and Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin Chem 54 (2008) 752-756
7. Rehman S.U., Martinez-Rumayor A., Mueller T., and Januzzi Jr. J.L. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta 392 (2008) 41-45
8. Weimberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., and Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107 (2003) 721-726
9. Rehman S.U., Mueller T., and Januzzi Jr. J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52 (2008) 1458-1465
10. Oshikawa K., Kuroiwa K., Tago K., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164 (2001) 277-281
11. Kuroiwa K., Arai T., Okazaki H., Minota S., and Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284 (2001) 1104-1108
12. Sweet M.J., Leung B.P., Kang D., et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 166 (2001) 6633-6639
13. Leung B.P., Xu D., Culshaw S., McInnes I.B., and Liew F.Y. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 173 (2004) 145-150